Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden

被引:396
作者
Murray, Anne M. [1 ,2 ,3 ,4 ]
机构
[1] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA
[2] Hennepin Cty Med Ctr, Dept Med, Div Geriatr, Minneapolis, MN 55415 USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Nephrol, Minneapolis, MN USA
关键词
cognitive impairment; delirium; dementia; hemodialysis; chronic kidney disease;
D O I
10.1053/j.ackd.2008.01.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The high burden of cognitive impairment in hemodialysis and chronic kidney disease (CKD) patients has only recently become recognized. Up to 70% of hemodialysis patients aged 55 years and older have moderate to severe chronic cognitive impairment, yet it is largely undiagnosed. Recent studies describe the strong graded relation between estimated glomerular filtration rate and cognitive function in CKD patients. The process of conventional hemodialysis may induce recurrent episodes of acute cerebral ischemia, which, in turn, may contribute to acute decline in cognitive function during dialysis. Thus, the worst time to communicate with dialysis patients may be during the hemodialysis session. Both symptomatic and occult, subclinical ischemic cerebrovascular disease appears to play a large role in a proposed model of accelerated vascular cognitive impairment in these populations. Severe cognitive impairment or dementia among hemodialysis patients is associated with an approximately 2-fold increased risk of both mortality and dialysis withdrawal. Predialysis cognitive screening and adding dementia to the list of comorbidities; on Form 2728 would provide critical information regarding the benefit versus risks of receiving dialysis. It could also improve quality of care and outcomes by raising clinicians' awareness of the potential effects of cognitive impairment on medication, fluid, and dietary compliance and the ability to make advance directive decisions among dialysis patients. Although much remains to be learned regarding the pathophysiology of cognitive impairment in kidney disease, the public health implications of this substantial burden are immediate. (c) 2008 by the National Kidney Foundation, Inc.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 83 条
[1]
Agildere AM, 2001, EUR RADIOL, V11, P1063
[2]
[Anonymous], DIAGN STAT MAN MENT
[3]
[Anonymous], 2006, USRDS 2006 ANN DAT R
[5]
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[6]
Dietary patterns and risk of dementia - The three-city cohort study [J].
Barberger-Gateau, P. ;
Raffaitin, C. ;
Letenneur, L. ;
Berr, C. ;
Tzourio, C. ;
Dartigues, J. F. ;
Alperovitch, A. .
NEUROLOGY, 2007, 69 (20) :1921-1930
[7]
Silent MRI infarcts and the risk of future stroke - The cardiovascular health study [J].
Bernick, C ;
Kuller, L ;
Dulberg, C ;
Longstreth, WT ;
Manolio, T ;
Beauchamp, N ;
Price, T .
NEUROLOGY, 2001, 57 (07) :1222-1229
[8]
Blood-brain barrier impairment in Alzheimer disease - Stability and functional significance [J].
Bowman, G. L. ;
Kaye, J. A. ;
Moore, M. ;
Waichunas, D. ;
Carlson, N. E. ;
Quinn, J. F. .
NEUROLOGY, 2007, 68 (21) :1809-1814
[9]
COGNITIVE CORRELATES OF VENTRICULAR ENLARGEMENT AND CEREBRAL WHITE-MATTER LESIONS ON MAGNETIC-RESONANCE-IMAGING - THE ROTTERDAM STUDY [J].
BRETELER, MMB ;
VANAMERONGEN, NM ;
VANSWIETEN, JC ;
CLAUS, JJ ;
GROBBEE, DE ;
VANGIJN, J ;
HOFMAN, A ;
VANHARSKAMP, F .
STROKE, 1994, 25 (06) :1109-1115
[10]
The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study [J].
Cao, Jie J. ;
Barzilay, Joshua I. ;
Peterson, Do ;
Manolio, Teri A. ;
Psaty, Bruce M. ;
Kuller, Lewis ;
Wexler, Jason ;
Bleyer, Anthony J. ;
Cushman, Mary .
ATHEROSCLEROSIS, 2006, 187 (02) :372-377